FIRST IN THE BALTICS: NORTHWAY BIOTECH OPENS €61 MILLION CELL THERAPY AND PERSONALIZED MEDICINE CDMO IN VILNIUS
5 Articles
5 Articles
FIRST IN THE BALTICS: NORTHWAY BIOTECH OPENS €61 MILLION CELL THERAPY AND PERSONALIZED MEDICINE CDMO IN VILNIUS
/PRNewswire/ -- The first dedicated Innovative Cell Therapy and Personalized Medicine Center of its kind in the Baltic States has opened in Vilnius, Lithuania,...
Northway Biotech, a subsidiary of the biotechnology and pharmaceutical group Northway, will officially open the EUR 61 million Innovative Cell Therapy and Personalized Medicine Center in the Vilnius Innovation Industrial Park (VIPP) in Vismaliukai on Thursday.
First in the Baltics: Northway Biotech Opens Euro 61 Million Cell Therapy and Personalized Medicine Cdmo in Vilnius
Building on more than 22 years of CDMO experience across biologics and advanced therapies, Northway Biotech is significantly expanding its development and manufacturing capacity with a new 3,500 sq. m facility featuring up to 20 [...]
Opening the first innovative cell therapy and personalized medicine center in the Baltic States in Vilnius on Thursday, Prime Minister Mindaugas Sinkevičius believes that this is a huge victory for Lithuania. According to him, the development of such projects determines that innovations and new jobs will be created in the country, where residents will be able to fulfill their potential. “This is a huge success for our country. Biosciences and bi…
The Northway Biotech group of companies, controlled by scientist and entrepreneur Vladas Algirdas Bumelis, is opening a EUR 61 million Innovative Cell Therapy and Personalized Medicine Center in Vilnius.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
